CENTOGENE N.V.
Centogene N.V. provides pharmaceutical solutions and diagnostic tests focusing on data-driven answers for rare and neurodegenerative diseases.
Classification
Profile
Funding
Funding details not yet available.
Essential life science partner providing data-driven answers for rare and neurodegenerative diseases to patients, physicians, and pharmaceutical companies.
Pharmaceutical companies, physicians, and patients, with global reach across Europe, the Middle East, North America, Latin America, and Asia Pacific.
Revenue derived from providing pharmaceutical solutions and diagnostic tests to a global market of industry and clinical clients.
Global distribution network operating across Europe, the Middle East, North America, Latin America, and the Asia Pacific.
Contract research organizations for clinical trials; healthcare providers and patient advocacy groups.
R&D, clinical trials, regulatory compliance, specialized manufacturing, and marketing.
Proprietary data-driven platform and pharmaceutical/diagnostic solutions focused on rare and neurodegenerative diseases.
Providing pharmaceutical solutions and diagnostic tests to deliver data-driven answers for rare and neurodegenerative disease contexts.
High-touch account management for pharma and large hospital systems - dedicated liaisons, quarterly business reviews, and custom data-sharin · Self-service portal with AI-driven variant interpretation - empowers clinicians to explore results, request re-analysis, and access educatio · Patient support programs - multilingual helplines, counseling re
Competes with other biopharma companies specializing in orphan drugs and rare diseases (e.g., Biogen, Protalix). Differentiates through its specific focus on LSTs and advanced vector technologies.
Need for data-driven answers and specialized pharmaceutical solutions for rare and neurodegenerative diseases for physicians and pharma.
- Credibility
No investors recorded yet.